Endocrine Abnormalities in Patients with Chronic Kidney Disease

1. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003; 228: 1-14.10.1177/15353702032280010112524467Search in Google Scholar

2. Dusso A, González EA, Martin KJ. Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab. 2011; 25: 647-55.10.1016/j.beem.2011.05.00521872805Search in Google Scholar

3. Iglesias P, Carrero JJ, Díez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol. 2012; 25: 31-42.10.5301/JN.2011.848121748720Search in Google Scholar

4. Ros S, Carrero JJ. Endocrine alterations and cardiovascular risk in CKD: Is there a link? Nefrologia. 2013; 33: 181-87.Search in Google Scholar

5. Carrero JJ, Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant. 2012; 27: 4030-41.10.1093/ndt/gfs38322962412Search in Google Scholar

6. Holley JL. The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis. 2004; 11: 337-41.10.1053/j.ackd.2004.07.004Search in Google Scholar

7. Sugiya N, Nakashima A, Takasugi N, et al. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life. Osteoporos Int. 2011; 22: 1573-9.10.1007/s00198-010-1350-y20652228Search in Google Scholar

8. Mak RH, Cheung WW, Roberts CT Jr. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res. 2008; 18: 17-25.10.1016/j.ghir.2007.07.009270614617826224Search in Google Scholar

9. Gupta D, Gardner M, Whaley-Connell A. Role of growth hormone deficiency and treatment in chronic kidney disease. Cardiorenal Med. 2011; 1: 174-82.10.1159/000329930315095922258540Search in Google Scholar

10. Wiezel D, Assadi MH, Landau D, Troib A, Kachko L, Rabkin R, Segev Y. Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease. Nephrol Dial Transplant. 2014; 29: 791-9.10.1093/ndt/gfu00324463190Search in Google Scholar

11. Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008; 23: 41-8.10.1007/s00467-007-0527-x210043417676425Search in Google Scholar

12. Salas P, Pinto V, Rodriguez J, Zambrano MJ, Mericq V. Growth retardation in children with kidney disease. Int J Endocrinol. 2013; doi: 10.1155/2013/97094610.1155/2013/970946380063524187550Search in Google Scholar

13. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med. 2000; 343: 923-30.10.1056/NEJM20000928343130411006368Search in Google Scholar

14. Mehls O, Lindberg A, Nissel R, Haffner D, Hokken- Koelega A, Ranke MB. Predicting the response to growth hormone treatment in short children with chronic kidney disease. J Clin Endocrinol Metab. 2010; 95: 686-9210.1210/jc.2009-111420008024Search in Google Scholar

15. Iglesias P, Díez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009; 160: 503-15.10.1530/EJE-08-083719095779Search in Google Scholar

16. Abdel-Rahman EM, Mansour W, Holley JL. Thyroid hormone abnormalities and frailty in elderly patients with chronic kidney disease: a hypothesis. Semin Dial. 2010; 23: 317-23.10.1111/j.1525-139X.2010.00736.x20636925Search in Google Scholar

17. Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012; 16: 204-13.10.4103/2230-8210.93737331373722470856Search in Google Scholar

18. Mohamedali M, Reddy Maddika S, Vyas A, Iyer V, Cheriyath P. Thyroid disorders and chronic kidney disease. Int J Nephrol. 2014; doi: 10.1155/2014/520281.10.1155/2014/520281400912124829799Search in Google Scholar

19. Xu G, Yan W, Li J. An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases. Clin Exp Nephrol. 2014; 18: 837-43.10.1007/s10157-014-0974-124752472Search in Google Scholar

20. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in endstage renal disease. Kidney Int. 2006; 70: 523-810.1038/sj.ki.500156616775599Search in Google Scholar

21. Lu Y, Ku E, Campese VM, Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Curr Hypertens Rep. 2010; 12: 303-6.10.1007/s11906-010-0116-420596805Search in Google Scholar

22. Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol. 2012; 2012: 691369.10.1155/2012/691369342035022919275Search in Google Scholar

23. Siew ED, Ikizler TA. Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Semin Dial. 2010; 23: 378-82.10.1111/j.1525-139X.2010.00763.x20701717Search in Google Scholar

24. Adamczak M, Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol. 2013; 33: 2-13. 10.1016/j.semnephrol.2012.12.00823374889Search in Google Scholar